Cart
sales@molnova.com
AWD 12-281
CAS No. 257892-33-4
AWD 12-281( —— )
Catalog No. M34515 CAS No. 257892-33-4
AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAWD 12-281
-
NoteResearch use only, not for human use.
-
Brief DescriptionAWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).
-
DescriptionAWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number257892-33-4
-
Formula Weight458.27
-
Molecular FormulaC22H14Cl2FN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC=1C(Cl)=CN=CC1Cl)C(=O)C2=CN(C=3C=CC(O)=CC23)CC4=CC=C(F)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-8380
Potent autotaxin inhibitor (IC50?= 2.8 nM in isolated enzyme assay; 101 nM in human whole blood).
-
Imazodan hydrochlori...
Imazodan hydrochloride (CI-914 HCl) is a potent and selective type III phosphodiesterase inhibitor used in the treatment of chronic congestive heart failure.
-
Imazodan
Imazodan, a small molecule compound with positive inotropic activity, is a selective type III phosphodiesterase inhibitor and can be used to study heart failure.
